383 related articles for article (PubMed ID: 31117076)
1. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
Notarangelo FM; Beggiato S; Schwarcz R
Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
[TBL] [Abstract][Full Text] [Related]
2. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
[TBL] [Abstract][Full Text] [Related]
3. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
[TBL] [Abstract][Full Text] [Related]
4. Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain.
Notarangelo FM; Schwarcz R
Dev Neurosci; 2016; 38(6):458-468. PubMed ID: 28214871
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
6. Kynurenate production by cultured human astrocytes.
Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
[TBL] [Abstract][Full Text] [Related]
7. A single prenatal lipopolysaccharide injection has acute, but not long-lasting, effects on cerebral kynurenine pathway metabolism in mice.
Notarangelo FM; Schwarcz R
Eur J Neurosci; 2021 Sep; 54(6):5968-5981. PubMed ID: 34363411
[TBL] [Abstract][Full Text] [Related]
8. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.
Amori L; Guidetti P; Pellicciari R; Kajii Y; Schwarcz R
J Neurochem; 2009 Apr; 109(2):316-25. PubMed ID: 19226371
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.
Yu P; Di Prospero NA; Sapko MT; Cai T; Chen A; Melendez-Ferro M; Du F; Whetsell WO; Guidetti P; Schwarcz R; Tagle DA
Mol Cell Biol; 2004 Aug; 24(16):6919-30. PubMed ID: 15282294
[TBL] [Abstract][Full Text] [Related]
10. Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain.
Ceresoli-Borroni G; Schwarcz R
Amino Acids; 2000; 19(1):311-23. PubMed ID: 11026502
[TBL] [Abstract][Full Text] [Related]
11. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
[TBL] [Abstract][Full Text] [Related]
12. Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations.
Herédi J; Cseh EK; Berkó AM; Veres G; Zádori D; Toldi J; Kis Z; Vécsei L; Ono E; Gellért L
Brain Res Bull; 2019 Mar; 146():185-191. PubMed ID: 30639278
[TBL] [Abstract][Full Text] [Related]
13. Subchronic
Blanco Ayala TB; Ramírez Ortega DR; Ovalle Rodríguez PO; Pineda B; Pérez de la Cruz GP; González Esquivel DG; Schwarcz R; Sathyasaikumar KV; Jiménez Anguiano AJ; Pérez de la Cruz VP
Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33498402
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
16. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
[TBL] [Abstract][Full Text] [Related]
17. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
18. Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.
Notarangelo FM; Wang XD; Horning KJ; Schwarcz R
J Neurochem; 2016 Feb; 136(4):804-814. PubMed ID: 26661897
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
[TBL] [Abstract][Full Text] [Related]
20. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
